TAKEDA PHARMACEUTICAL CO LTD (TAK)
Clinical trial NCT05156983 updates: 1. completion date: 2028-04-12 → 2028-08-30 2. primary completion date: 2028-04-12 → 2028-08-30 3. enrollment: 328 → 440 participants
Clinical trial NCT05156983 updates: 1. completion date: 2028-04-12 → 2028-08-30 2. primary completion date: 2028-04-12 → 2028-08-30 3. enrollment: 328 → 440 participants
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical